Catalyst Wire Dossier Catalyst Wire Dossier

Personalized cancer vaccine immunotherapy

· Emory University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Personalized cancer vaccine immunotherapy, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer [Phase 1]

See pricing